Venn Life Sciences - part of hVIVO plc

Don’t miss our upcoming FREE Webinar ‘Anticipating Challenges: Clinical Pharmacology Insights on the Translation From Preclinical to Clinical’! This webinar will explore key considerations from a clinical pharmacology perspective and explore potential solutions to establish a robust plan for your First-In-Human (FIH) study. 📅 Date: Tuesday 19th November 2024 🕒Time: 4-5pm Amsterdam time 🎙️Speaker: Tom Habraken, Group Leader of Clinical Consultancy at Venn Life Sciences - part of hVIVO plc 🔑Key Learnings: • Key elements in the transition from preclinical to clinical • How the target population shapes FIH trials for your drug • Understanding the role of drug-drug interactions in the early clinical development of your drug • Handling unexpected pharmacokinetic results in your first-in-human study Sign Up Now using the registration link! #Webinar #DrugDevelopment #Preclinical #Clinical #Pharmacology

🎤 André Wolterbeek, our Head of Non-Clinical Development, was honoured to give a #TechTalk last month in Leiden Bio Science Park! André delved into innovative approaches for advancing science without relying on traditional test-animal models as alternative methods in non-clinical development. 🔬 If you are interested in exploring more and finding out how Venn Life Sciences can support your non-clinical programs, enquire here 🌐 https://lnkd.in/eRkS9j_y #Venn #NonClinical #AnimalFree #Innovation

Congratulations to Arthur Noach on an incredible 25 Years at Venn Life Sciences! 🎉 Earlier this month, we hosted an event to celebrate Arthur's remarkable journey with us! We reminisced about unforgettable moments he has shared as a colleague, mentor and friend. For those who don’t know Arthur, he was one of our first employees at Venn, starting as a Pharmacokinetics Consultant and now a Non-Clinical Senior Consultant. His contributions and expertise have been nothing less than transformative. Here’s to more years of Arthur at Venn! #Venn #DrugDevelopment #25Years #WorkAnniversary

We are attending this year’s BIO-Europe event EBD Group! Join us in Stockholm on the 4-6 November and learn more about how Venn Life Sciences can help accelerate your drug development from lab to patient fast and efficiently. Meet with Lucia Santoso, our Director of Business Development, and Winnie Hendrikx, Business Development Manager and Clinical PK Consultant, to discuss how our team of consultancy experts can be your drug development partners, from start to finish. 🤝 Reach out to Lucia and Winnie and connect with them at BIO-Europe! #Venn #BioEurope #DrugDevelopment #Europe

The Chemistry, Manufacturing, and Controls (CMC) division is pivotal in pharmaceutical production, ensuring product quality, safety, and efficacy. At Venn Life Sciences, we cover from early to late phase CMC and support in: • CMC management and strategy development • Drug Substance process development • Drug Product formulation & process development • Analytical development • ATMP development • Medical devices Download and read our latest factsheet on CMC Early Phase Development here: https://lnkd.in/e6wBi9QP #Venn #DrugDevelopment #CMC #ATMP #MedicalDevices

As an Integrated Drug Development partner, from discovery to Phase II, we offer a unique combination of drug development consultancy, clinical trial design and execution. This enables us to help you create, plan and execute drug development programmes effectively. One of our pillars is our long-term partnerships, with over 90% of our work coming from repeat business. Check out our recent testimonial from VarmX. You can see what our clients say about us here: https://lnkd.in/d5QVzmDJ #Venn #Testimonials #DrugDevelopment #IntegratedPartner #Consultancy

It was amazing to see Katsuhiro Mihara, RPh, PhD and John Dulos reunited, 22 years from their time as colleagues at Organon/MSD for Venn’s webinar on Turning Setbacks into Success: Translational Science in Action. During the webinar, John discussed the crucial role of translational science, how laboratory findings are transformed into patient treatments, and case studies outlining where initial failures were turned into unexpected opportunities. If you have not yet had the chance to watch the webinar, you can watch it on demand here: https://lnkd.in/e4X6tXAJ #Venn #TranslationalScience #DrugDevelopment #Collaboration #Pharma #Biomarker

Our Project Manager of Biosample Operations, Simone van Broekhoven, will be attending Introduction to Oncology for Clinical Researchers, hosted by European Centre for Clinical Research Training (ECCRT), on 22-23 October in Brussels. 🤝Connect with Simone if you’re also attending! #Venn #Oncology #Cancer #ClinicalResearch #Healthcare

We had the pleasure to host our annual 5-day virtual #Pharmacokinetics course. Thank you to all those who attended! Our Venn non-clinical & clinical experts were honoured to cover a range of key topics, ranging from biological process to calculations within drug development💊 Check out some of the photos of our experts presenting. If you are interested in joining next year’s certified course, contact us🔗 https://lnkd.in/eRkS9j_y #Venn #NonClinical #Clinical #Pharmacokinetics #DrugDevelopment

🚨 FREE Webinar - Sign Up Now! 🚨 Join our upcoming webinar to learn how the estimand framework is revolutionising the way we define and analyse research questions. 💡 📅 Date: Tuesday 15th October 2024 🕒 Time: 2:30-4:30pm Paris time 🎙️Speakers: Elodie Blondiaux & Stéphane Verdun 👥 Hosted by: Venn Life Sciences We’ll explain the concept of estimands, explore strategies for handling intercurrent events, and showcase real-world examples of how interdisciplinary collaboration is key to achieving valid inferences. 🚀 Don’t miss this opportunity to sharpen your clinical research skills! Register here: https://lnkd.in/e-_eTpbv #Webinar #Estimands #ClinicalTrials #Biostatistics